IONIS PHARMACEUTICALS INC — Director's Dealing 2023

Dec 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2023-12-14

Reporting Person: YANG MICHAEL J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-14	Non-Qualified Stock Option (right to buy)	$49.82	A	12356	Acquired	2033-12-14	Common Stock (12356)	Direct

Footnotes

F1: Grant of 12/14/2023 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in three equal annual installments, the first installment vesting on 12/14/2024. The option shall be fully vested and exercisable on 12/14/2026. The stock option was exercisable as to 0 shares on 12/14/2023.